Mitigating N-nitroso Impurities in the API Manufacturing Process
In the pharmaceutical industry, the development and manufacture of Active Pharmaceutical Ingredients (APIs) require meticulous attention to quality control and impurity management. One particularly challenging class of impurities to address is the N-nitrosamines, also known as N-nitroso compounds. These impurities have garnered significant attention in recent years due to their potential carcinogenic properties, leading to increased regulatory scrutiny and the need for robust strategies to mitigate their formation during the API manufacturing process. As a leading API impurity standard supplier in India , Aquigen Bio Sciences has extensive expertise in addressing the challenge of N-nitroso impurities. In this blog, we will explore the sources of N-nitroso impurities, discuss effective strategies for minimizing their formation, and highlight how Aquigen Bio Sciences can assist pharmaceutical companies in manufacturing APIs with low N-nitroso impurity levels. Sources of N-nitroso Im...